Why the study?
Do steroid-eluting epicardial leads improve energy thresholds compared to nonsteroid epicardial leads in pediatric patients?
Do steroid-eluting epicardial leads improve energy thresholds compared to nonsteroid epicardial leads in pediatric patients?
Steroid-eluting epicardial leads improve pacing thresholds and potential pacemaker longevity compared to nonsteroid leads in pediatric patients.
Answers are grounded in this paper and cite their sources.
May support steroid-eluting epicardial leads to potentially extend device longevity in children; hypothesis-generating and requires randomized confirmation.
From 1986 to 1991, we evaluated the clinical use of three new epicardial lead designs incorporating a steroid-eluting electrode. Medtronic models SP2114 (bipolar high profile), 10320 (bipolar low profile), 10295A/4965 (unipolar low profile) steroid epicardial (SE) leads were used on either atrium or ventricle for a total of 21 lead placements in 17 patients. Energy thresholds (T) were calculated and compared with our most recent 16 nonsteroid epicardial (NE) Medtronic model 4951 lead implants for which T was available. SE leads demonstrated no acute T rise and continued T improvements at 1 year of follow-up. We conclude that epicardial application of SE lead technology offers a major improvement in pacing lead function and potential pacemaker longevity over NE leads in pediatric patients in whom endocardial pacing is precluded by size or anatomy.
No takes yet. Share an insight, caveat, or question.
Hamilton et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: